Clinical trials in Africa: Where there is a challenge, there is an opportunity - Clinical Trials Arena

clinicaltrialsarena.com · 554 words · saved by 1 readers

The challenges and opportunities surrounding Africa becoming a clinical trials global force were discussed on day one of CTS Europe. Over 18% of the global population lives in Africa, but less than 3% of clinical trials are conducted there. Is there an opportunity for clinical trials to be conducted in Africa? Experts at the ongoing Clinical Trial Supply (CTS) Europe meeting say the answer is yes, but not without its challenges. Leading the session, “Increasing diversity: supply chain considerations for clinical trials in Africa”, Révérien Uwacu, clinical trial supply management consultant for the pharma company UCB, emphasised the importance of diversity in clinical trials, for scientific, moral, and medical reasons. Révérien cited logistical challenges and regulatory complexities in trial supply management, as some of the reasons behind this lack of diversity. Despite this, increased regulatory support and interest in local research sites can increase the potential of clinical trials

Révérien Uwacu speaking about the five African countries that have a WHO maturity level of three, signifying high capability of overseeing clinical trials. Image credit: Jenna Philpott/GlobalData. Over 18% of the global population lives in Africa, but less than 3% of clinical trials are conducted there. Is there an opportunity for clinical trials to be conducted in Africa ? Experts at the ongoing Clinical Trial Supply (CTS) Europe meeting say the answer is yes, but not without its challenges. Leading the session, “Increasing diversity: supply chain considerations for clinical trials in Africa”

Clinical trials in Africa: Where there is a challenge, there is an opportunity - Clinical Trials Arena

related reading